US6331318B1
(en)
*
|
1994-09-30 |
2001-12-18 |
Emisphere Technologies Inc. |
Carbon-substituted diketopiperazine delivery systems
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5541155A
(en)
*
|
1994-04-22 |
1996-07-30 |
Emisphere Technologies, Inc. |
Acids and acid salts and their use in delivery systems
|
US6099856A
(en)
|
1992-06-15 |
2000-08-08 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5443841A
(en)
|
1992-06-15 |
1995-08-22 |
Emisphere Technologies, Inc. |
Proteinoid microspheres and methods for preparation and use thereof
|
US6221367B1
(en)
|
1992-06-15 |
2001-04-24 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5578323A
(en)
|
1992-06-15 |
1996-11-26 |
Emisphere Technologies, Inc. |
Proteinoid carriers and methods for preparation and use thereof
|
US5693338A
(en)
*
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
US5629020A
(en)
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
US5352461A
(en)
*
|
1992-03-11 |
1994-10-04 |
Pharmaceutical Discovery Corporation |
Self assembling diketopiperazine drug delivery system
|
US6916489B2
(en)
*
|
1992-06-15 |
2005-07-12 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5811127A
(en)
|
1992-06-15 |
1998-09-22 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5792451A
(en)
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US5401516A
(en)
|
1992-12-21 |
1995-03-28 |
Emisphere Technologies, Inc. |
Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
|
US5709861A
(en)
|
1993-04-22 |
1998-01-20 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US6461643B2
(en)
|
1993-04-22 |
2002-10-08 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US5643957A
(en)
|
1993-04-22 |
1997-07-01 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
EP1025840B1
(de)
|
1993-04-22 |
2005-06-29 |
Emisphere Technologies, Inc. |
Orale Dareichungsform
|
US20010003001A1
(en)
|
1993-04-22 |
2001-06-07 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5958457A
(en)
|
1993-04-22 |
1999-09-28 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
US6794357B1
(en)
*
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US5466259A
(en)
*
|
1994-03-07 |
1995-11-14 |
Durette; Jean-Francois |
Orbital implant and method
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
BR9510510A
(pt)
|
1994-12-22 |
1998-07-07 |
Astra Ab |
Formulação em aerossol farmacêutica uso da mesma e processos para fabricação da mesma para tratamento de um paciente carente de terapia
|
US6524557B1
(en)
*
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
US6001347A
(en)
|
1995-03-31 |
1999-12-14 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5965121A
(en)
|
1995-03-31 |
1999-10-12 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5989539A
(en)
|
1995-03-31 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6090958A
(en)
|
1995-03-31 |
2000-07-18 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5650386A
(en)
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
BR9604880A
(pt)
|
1995-03-31 |
1998-05-19 |
Emisphere Tech Inc |
Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
|
US5820881A
(en)
|
1995-04-28 |
1998-10-13 |
Emisphere Technologies, Inc. |
Microspheres of diamide-dicarboxylic acids
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US5824345A
(en)
*
|
1995-06-07 |
1998-10-20 |
Emisphere Technologies, Inc. |
Fragrances and flavorants
|
US5750147A
(en)
|
1995-06-07 |
1998-05-12 |
Emisphere Technologies, Inc. |
Method of solubilizing and encapsulating itraconazole
|
US5667806A
(en)
|
1995-06-07 |
1997-09-16 |
Emisphere Technologies, Inc. |
Spray drying method and apparatus
|
US6051258A
(en)
|
1995-06-07 |
2000-04-18 |
Emisphere Technologies, Inc. |
Proteinoid emulsions and methods for preparation and use thereof
|
GB2320248B
(en)
|
1995-09-11 |
1999-04-14 |
Emisphere Tech Inc |
Method for preparing omega-aminoalkanoic acid derivatives from cycloalkanones
|
WO1997017985A1
(en)
*
|
1995-11-13 |
1997-05-22 |
Smithkline Beecham Corporation |
Hemoregulatory compounds
|
SI9720025A
(sl)
|
1996-03-29 |
1999-08-31 |
Emishphere Technologies, Inc. |
Spojine in sestavki za prenos aktivne snovi
|
AU3828597A
(en)
|
1996-06-14 |
1998-01-07 |
Emisphere Technologies, Inc. |
Microencapsulated fragrances and method for preparation
|
WO1998021951A1
(en)
|
1996-11-18 |
1998-05-28 |
Emisphere Technologies, Inc. |
Methods and compositions for inducing oral tolerance in mammals
|
US6313088B1
(en)
|
1997-02-07 |
2001-11-06 |
Emisphere Technologies, Inc. |
8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
|
US6358504B1
(en)
|
1997-02-07 |
2002-03-19 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6060513A
(en)
|
1997-02-07 |
2000-05-09 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5990166A
(en)
|
1997-02-07 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5879681A
(en)
|
1997-02-07 |
1999-03-09 |
Emisphere Technolgies Inc. |
Compounds and compositions for delivering active agents
|
US5804688A
(en)
|
1997-02-07 |
1998-09-08 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5939381A
(en)
|
1997-02-07 |
1999-08-17 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5876710A
(en)
|
1997-02-07 |
1999-03-02 |
Emisphere Technologies Inc. |
Compounds and compositions for delivering active agents
|
US5863944A
(en)
|
1997-04-30 |
1999-01-26 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5962710A
(en)
|
1997-05-09 |
1999-10-05 |
Emisphere Technologies, Inc. |
Method of preparing salicyloylamino acids
|
US5891237A
(en)
*
|
1997-10-08 |
1999-04-06 |
Millennium Inorganic Chemicals, Ltd. |
Production of free flowing spheres using partially neutralized fatty acid
|
WO2000006184A1
(en)
|
1998-07-27 |
2000-02-10 |
Emisphere Technologies, Inc. |
Pulmonary delivery of active agents
|
US6440929B1
(en)
|
1998-07-27 |
2002-08-27 |
Emisphere Technologies, Inc. |
Pulmonary delivery of active agents
|
US6991798B1
(en)
|
1998-08-07 |
2006-01-31 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
JP4430235B2
(ja)
*
|
1998-08-07 |
2010-03-10 |
エミスフェアー・テクノロジーズ・インク |
活性剤のデリバリーのための化合物及び組成物
|
BR0008590A
(pt)
*
|
1999-01-08 |
2001-10-30 |
Emisphere Tech Inc |
Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
|
EP1156812A4
(de)
*
|
1999-02-23 |
2004-09-29 |
Isis Pharmaceuticals Inc |
Multipartikuläre formulierung
|
WO2000050386A1
(en)
|
1999-02-26 |
2000-08-31 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
CA2369591C
(en)
*
|
1999-04-05 |
2011-06-14 |
Emisphere Technologies, Inc. |
Disodium salts, monohydrate, and ethanol solvates
|
PT1808438E
(pt)
*
|
1999-06-29 |
2015-01-14 |
Mannkind Corp |
Purificação e estabilização de péptidos e proteínas em agentes farmacêuticos
|
AU2012201760B2
(en)
*
|
1999-06-29 |
2015-04-16 |
Mannkind Corporation |
Purification and stabilization of peptide and protein pharmaceutical agents
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US7129274B1
(en)
|
1999-11-05 |
2006-10-31 |
Emisphere Technologies Inc. |
Phenoxy carboxylic acid compounds and compositions for delivering active agents
|
US7279597B1
(en)
|
1999-11-05 |
2007-10-09 |
Emisphere Technologies, Inc. |
Phenyl amine carboxylic acid compounds and compositions for delivering active agents
|
ATE427743T1
(de)
|
1999-11-15 |
2009-04-15 |
Biocure Inc |
Auf aussere bedingungen ansprechende polymere hohle partikel
|
AU2274201A
(en)
|
1999-12-16 |
2001-06-25 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US7833549B2
(en)
*
|
2000-01-19 |
2010-11-16 |
Mannkind Corporation |
Dry powder formulations of antihistamine for nasal administration
|
US6808707B2
(en)
|
2000-02-04 |
2004-10-26 |
Matrix Design |
Wound healing compositions and methods using tropoelastin and lysyl oxidase
|
DE10019879A1
(de)
*
|
2000-04-20 |
2001-10-25 |
Degussa |
Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung
|
US6537968B1
(en)
*
|
2000-07-24 |
2003-03-25 |
Alphamed Pharmaceuticals Corp |
Treatment of lupus erythematosus
|
PT1311269E
(pt)
*
|
2000-08-04 |
2012-05-10 |
Dmi Biosciences Inc |
Método de utilização de dicetopiperazinas e composição que contém as mesmas
|
WO2002062797A2
(en)
*
|
2000-12-29 |
2002-08-15 |
Celltech R & D, Inc. |
Pharmaceutical uses and synthesis of diketopiperazines
|
US20030225300A1
(en)
*
|
2001-04-19 |
2003-12-04 |
Emisphere Technologies Inc. |
Compounds and compositions for delivering active agents
|
US6991779B2
(en)
*
|
2002-01-18 |
2006-01-31 |
Mannkind Corporation |
Compositions for treatment or prevention of bioterrorism
|
WO2003080149A2
(en)
|
2002-03-20 |
2003-10-02 |
Mannkind Corporation |
Inhalation apparatus
|
US7053034B2
(en)
*
|
2002-04-10 |
2006-05-30 |
Salvona, Llc |
Targeted controlled delivery compositions activated by changes in pH or salt concentration
|
AU2003234240A1
(en)
*
|
2002-04-23 |
2003-11-10 |
Teva Pharmaceutical Industries Ltd. |
Pharmaceutical composition containing lamotrigine particles of defined morphology
|
DE60326709D1
(de)
*
|
2002-04-29 |
2009-04-30 |
Supernus Pharmaceuticals Inc |
Pharmazeutische formulierungen mit verbesserter bioverfügbarkeit
|
US20080260838A1
(en)
*
|
2003-08-01 |
2008-10-23 |
Mannkind Corporation |
Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
|
US20040038865A1
(en)
*
|
2002-08-01 |
2004-02-26 |
Mannkind Corporation |
Cell transport compositions and uses thereof
|
EP1545457A4
(de)
*
|
2002-08-01 |
2009-07-01 |
Mannkind Corp |
Zelltransport-zusammensetzungen und ihre verwendungen
|
US20040171518A1
(en)
*
|
2003-02-27 |
2004-09-02 |
Medtronic Minimed, Inc. |
Compounds for protein stabilization and methods for their use
|
US20040224024A1
(en)
*
|
2003-04-23 |
2004-11-11 |
Massachusetts Institute Of Technology |
Controlled drug release formulations containing polyion complexes
|
EP2537524B1
(de)
*
|
2003-05-15 |
2016-07-06 |
Ampio Pharmaceuticals, Inc. |
Behandlung von T-Zell-vermittelten Krankheiten
|
KR20060054371A
(ko)
*
|
2003-07-31 |
2006-05-22 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
캡슐화 및 제어된 방출을 위한 조성물
|
US8921311B2
(en)
|
2003-08-01 |
2014-12-30 |
Mannkind Corporation |
Method for treating hyperglycemia
|
US7795007B2
(en)
|
2003-09-23 |
2010-09-14 |
Wisconsin Alumni Research Foundation |
Detection of post-translationally modified peptides with liquid crystals
|
US8133680B2
(en)
*
|
2003-09-23 |
2012-03-13 |
Wisconsin Alumni Research Foundation |
Using liquid crystals to detect affinity microcontact printed biomolecules
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
US20070027063A1
(en)
*
|
2004-01-12 |
2007-02-01 |
Mannkind Corporation |
Method of preserving the function of insulin-producing cells
|
EP1708738B1
(de)
*
|
2004-01-12 |
2016-05-04 |
MannKind Corporation |
Verfahren zur verringerung des proinsulinspiegels im serum bei zuckerkranken mit type 2 diabetes
|
JP2005209106A
(ja)
*
|
2004-01-26 |
2005-08-04 |
Nec Corp |
携帯通信端末、受信メール管理方法、プログラムおよび記録媒体
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
PT2319500E
(pt)
*
|
2004-03-12 |
2013-01-23 |
Biodel Inc |
Composições de distribuição de fármacos de actuação rápida
|
JP5078014B2
(ja)
*
|
2004-08-20 |
2012-11-21 |
マンカインド コーポレイション |
ジケトピペラジン合成の触媒反応
|
EP1781254A2
(de)
*
|
2004-08-23 |
2007-05-09 |
Mannkind Corporation |
Pulmonale abgabe von inhibitoren des typs phosphodiesterase-5
|
HUE026797T2
(en)
|
2004-08-23 |
2016-07-28 |
Mannkind Corp |
Diceto-piperazine salts for drug delivery
|
WO2006086107A2
(en)
*
|
2005-01-10 |
2006-08-17 |
Mannkind Corporation |
Methods and compositions for minimizing accrual of inhalable insulin in the lungs
|
CN101346468B
(zh)
|
2005-06-15 |
2016-03-30 |
麻省理工学院 |
含胺脂质和其用途
|
US20070004036A1
(en)
*
|
2005-07-01 |
2007-01-04 |
Rodolfo Faudoa |
Methods and compositions for keratinocyte culture
|
US20070128685A1
(en)
*
|
2005-07-01 |
2007-06-07 |
Rodolfo Faudoa |
Methods and compositions for cell culture
|
US20070003541A1
(en)
*
|
2005-07-01 |
2007-01-04 |
Rodolfo Faudoa |
Methods and compositions for therapeutics
|
KR20120060245A
(ko)
|
2005-09-14 |
2012-06-11 |
맨카인드 코포레이션 |
활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
ATE465087T1
(de)
|
2005-11-21 |
2010-05-15 |
Mannkind Corp |
Gerät und verfahren zur pulverausgabe und messung
|
EP2497484A3
(de)
*
|
2006-02-22 |
2012-11-07 |
MannKind Corporation |
Verfahren zur Verbesserung der pharmazeutischen Eigenschaften von Mikropartikeln mit Diketopiperazin und einem Wirkstoff
|
US7718609B2
(en)
|
2006-04-12 |
2010-05-18 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
EP2010155A2
(de)
*
|
2006-04-14 |
2009-01-07 |
MannKind Corporation |
Pharmazeutische glucagon-ähnliche peptid1-formulierungen
|
AU2007280995C1
(en)
*
|
2006-08-04 |
2013-05-23 |
Manus Pharmaceuticals (Canada) Ltd. |
Multifunctional bioactive compounds
|
WO2008054725A2
(en)
|
2006-10-31 |
2008-05-08 |
Surmodics Pharmaceuticals, Inc. |
Spheronized polymer particles
|
US8785396B2
(en)
|
2007-10-24 |
2014-07-22 |
Mannkind Corporation |
Method and composition for treating migraines
|
WO2009055740A2
(en)
|
2007-10-24 |
2009-04-30 |
Mannkind Corporation |
Method of preventing adverse effects by glp-1
|
KR20100090692A
(ko)
*
|
2007-10-24 |
2010-08-16 |
맨카인드 코포레이션 |
활성제의 전달
|
MX2010007342A
(es)
*
|
2008-01-04 |
2010-08-26 |
Biodel Inc |
Formulaciones de insulina para la liberacion de insulina como una funcion de los niveles de glucosa en el tejido.
|
EP2300011A4
(de)
|
2008-05-27 |
2012-06-20 |
Dmi Life Sciences Inc |
Therapeutische verfahren und verbindungen
|
EP3281663B8
(de)
|
2008-06-13 |
2022-09-21 |
MannKind Corporation |
Atemluftbetriebener trockenpulverinhalator zur verabreichung von medikamenten
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
US9364619B2
(en)
|
2008-06-20 |
2016-06-14 |
Mannkind Corporation |
Interactive apparatus and method for real-time profiling of inhalation efforts
|
BRPI0917568A2
(pt)
|
2008-08-05 |
2019-09-24 |
Mannkind Corp |
módulos distribuidores de pó e montagens distribuidas de pó aperfeiçoados
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
AU2009311667B2
(en)
|
2008-11-07 |
2016-04-14 |
Massachusetts Institute Of Technology |
Aminoalcohol lipidoids and uses thereof
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
DK2379511T3
(en)
*
|
2008-12-29 |
2015-01-12 |
Mannkind Corp |
Substituted diketopiperazinanaloger for use as pharmaceutical management funds
|
AU2010203573A1
(en)
|
2009-01-08 |
2011-06-30 |
Mannkind Corporation |
Method for treating hyperglycemia with GLP-1
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
TWI528982B
(zh)
|
2009-03-04 |
2016-04-11 |
曼凱公司 |
改良的乾粉藥物輸送系統
|
CA2754595C
(en)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
WO2010144789A2
(en)
*
|
2009-06-12 |
2010-12-16 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
EP3556356B1
(de)
*
|
2009-06-12 |
2021-05-05 |
MannKind Corporation |
Diketopiperazin-mikropartikel mit definiertem isomergehalt
|
US8642548B2
(en)
|
2009-08-07 |
2014-02-04 |
Mannkind Corporation |
Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
|
CN104801215B
(zh)
|
2009-11-02 |
2017-11-17 |
曼康公司 |
以沉淀过程产生药物颗粒的反应器
|
MX357798B
(es)
|
2009-11-02 |
2018-07-25 |
Mannkind Corp |
Aparato y método para la criogranulación de una composición farmacéutica.
|
CA2778698A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
NZ600616A
(en)
|
2009-12-01 |
2014-11-28 |
Shire Human Genetic Therapies |
Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
|
US9140651B2
(en)
|
2010-05-07 |
2015-09-22 |
Mannkind Corporation |
Determining percent solids in suspension using raman spectroscopy
|
AU2011271097B2
(en)
|
2010-06-21 |
2014-11-27 |
Mannkind Corporation |
Dry powder drug delivery system and methods
|
WO2012027675A2
(en)
|
2010-08-26 |
2012-03-01 |
Massachusetts Institute Of Technology |
Poly(beta-amino alcohols), their preparation, and uses thereof
|
WO2012033792A2
(en)
|
2010-09-07 |
2012-03-15 |
Dmi Acquisition Corp. |
Treatment of diseases
|
CN103200940A
(zh)
|
2010-11-09 |
2013-07-10 |
曼金德公司 |
用于治疗偏头痛的包含血清素受体激动剂和二酮哌嗪的组合物
|
KR20140027937A
(ko)
|
2011-02-10 |
2014-03-07 |
맨카인드 코포레이션 |
N보호된 비스3,6(4아미노알킬)2,5,디케토피페라진의 생성
|
DK2691443T3
(da)
|
2011-03-28 |
2021-05-03 |
Massachusetts Inst Technology |
Konjugerede lipomerer og anvendelser af disse
|
CN105667994B
(zh)
|
2011-04-01 |
2018-04-06 |
曼金德公司 |
用于药物药盒的泡罩包装
|
WO2012142320A2
(en)
|
2011-04-12 |
2012-10-18 |
Moerae Matrix Inc |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
EP2717861A1
(de)
*
|
2011-06-06 |
2014-04-16 |
Perosphere, Inc. |
Bioadhäsive wirkstofffreisetzungszusammensetzungen
|
EP4043025A1
(de)
|
2011-06-08 |
2022-08-17 |
Translate Bio, Inc. |
Lipidnanoteilchenzusammensetzungen und verfahren zur mrna-freisetzung
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
US8980834B2
(en)
|
2011-10-10 |
2015-03-17 |
Ampio Pharmaceuticals, Inc. |
Treatment of degenerative joint disease
|
WO2013055749A1
(en)
|
2011-10-10 |
2013-04-18 |
Ampio Pharmaceuticals, Inc. |
Implantable medical devices with increased immune tolerance, and methods for making and implanting
|
KR20140095483A
(ko)
|
2011-10-24 |
2014-08-01 |
맨카인드 코포레이션 |
통증을 치료하기 위한 방법 및 조성물
|
EP4074694A1
(de)
|
2011-10-27 |
2022-10-19 |
Massachusetts Institute Of Technology |
Aminosäure-, peptid- und polypeptide-lipoide, isomere, zusammensetzungen und verwendungen davon
|
BR112014008036A2
(pt)
|
2011-10-28 |
2017-04-11 |
Ampio Pharmaceuticals Inc |
tratamento de rinite
|
WO2013114374A1
(en)
|
2012-02-01 |
2013-08-08 |
Protalix Ltd. |
Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
|
JP6185489B2
(ja)
|
2012-02-09 |
2017-08-23 |
ノーバス・インターナショナル・インコーポレイテッドNovus International,Inc. |
機能性ポリマー組成物
|
CN104284918B
(zh)
*
|
2012-03-28 |
2017-03-29 |
高剑萍 |
氨酯型和脲酯型化合物及其制备方法
|
WO2013162764A1
(en)
|
2012-04-27 |
2013-10-31 |
Mannkind Corp |
Methods for the synthesis of ethylfumarates and their use as intermediates
|
US20150267192A1
(en)
|
2012-06-08 |
2015-09-24 |
Shire Human Genetic Therapies, Inc. |
Nuclease resistant polynucleotides and uses thereof
|
CA2878617A1
(en)
|
2012-07-12 |
2014-01-16 |
Houston Stephen Smith |
Matrix and layer compositions for protection of bioactives
|
DK2872205T3
(en)
|
2012-07-12 |
2017-02-27 |
Mannkind Corp |
DRY POWDER FORMAL ADMINISTRATION SYSTEM
|
WO2014028487A1
(en)
|
2012-08-13 |
2014-02-20 |
Massachusetts Institute Of Technology |
Amine-containing lipidoids and uses thereof
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
PE20151773A1
(es)
|
2013-03-14 |
2015-12-20 |
Shire Human Genetic Therapies |
COMPOSICIONES DE ARNm DE CFTR, METODOS Y USOS RELACIONADOS
|
ES2708561T3
(es)
|
2013-03-14 |
2019-04-10 |
Translate Bio Inc |
Métodos para la purificación de ARN mensajero
|
KR102499439B1
(ko)
|
2013-03-15 |
2023-02-13 |
맨카인드 코포레이션 |
미세결정성 디케토피페라진 조성물 및 방법
|
SG10201707619RA
(en)
|
2013-03-15 |
2017-10-30 |
Ampio Pharmaceuticals Inc |
Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
|
US9315472B2
(en)
|
2013-05-01 |
2016-04-19 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
WO2015010092A1
(en)
|
2013-07-18 |
2015-01-22 |
Mannkind Corporation |
Heat-stable dry powder pharmaceutical compositions and methods
|
JP2016530930A
(ja)
|
2013-08-05 |
2016-10-06 |
マンカインド コーポレイション |
通気装置及び方法
|
MX2016005239A
(es)
|
2013-10-22 |
2016-08-12 |
Shire Human Genetic Therapies |
Tratamiento con acido ribonucleico mensajero para la fenilcetonuria.
|
EP3060257B1
(de)
|
2013-10-22 |
2021-02-24 |
Translate Bio, Inc. |
Lipidzusammensetzungen zur verabreichung von mrna
|
EP4276176A3
(de)
|
2013-10-22 |
2024-01-10 |
Translate Bio, Inc. |
Mrna-therapie für argininosuccinat-synthase-mangel
|
WO2015148905A1
(en)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
KR20220158867A
(ko)
|
2014-04-25 |
2022-12-01 |
샤이어 휴먼 지네틱 테라피즈 인크. |
메신저 rna 의 정제 방법
|
JP6557722B2
(ja)
*
|
2014-05-30 |
2019-08-07 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
核酸の送達のための生分解性脂質
|
WO2015200465A1
(en)
|
2014-06-24 |
2015-12-30 |
Shire Human Genetic Therapies, Inc. |
Stereochemically enriched compositions for delivery of nucleic acids
|
WO2016004202A1
(en)
|
2014-07-02 |
2016-01-07 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
EP4066836A1
(de)
|
2014-08-18 |
2022-10-05 |
Ampio Pharmaceuticals, Inc. |
Behandlung von gelenkerkrankungen
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
WO2016057693A1
(en)
|
2014-10-10 |
2016-04-14 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
CA2967621A1
(en)
|
2014-11-17 |
2016-05-26 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
CA2978941A1
(en)
|
2015-03-12 |
2016-09-15 |
Moerae Matrix, Inc. |
Use of mk2 inhibitor peptide-containing compositions for treating non-small cell lung cancer with same
|
CN104961687B
(zh)
*
|
2015-06-03 |
2017-07-25 |
苏州维泰生物技术有限公司 |
1,2‑二嗪衍生物及其制剂、用途
|
RS64331B1
(sr)
|
2015-06-19 |
2023-08-31 |
Massachusetts Inst Technology |
Alkenil supstituisani 2,5-piperazindioni i njihova primena u sastavima za isporuku agensa u organizam ili ćeliju subjekta
|
WO2016209969A1
(en)
|
2015-06-22 |
2016-12-29 |
Ampio Pharmaceuticals, Inc. |
Use of low molecular weight fractions of human serum albumin in treating diseases
|
JP2019504684A
(ja)
*
|
2016-01-29 |
2019-02-21 |
マンカインド コーポレイション |
乾燥粉末吸入器
|
TW201809049A
(zh)
|
2016-03-31 |
2018-03-16 |
盧伯利索先進材料有限公司 |
生物可分解及/或生物可吸收的熱塑性聚胺甲酸酯
|
AU2018224326B2
(en)
|
2017-02-27 |
2024-01-04 |
Translate Bio, Inc. |
Novel codon-optimized CFTR mRNA
|
US11173190B2
(en)
|
2017-05-16 |
2021-11-16 |
Translate Bio, Inc. |
Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR
|
US10584306B2
(en)
|
2017-08-11 |
2020-03-10 |
Board Of Regents Of The University Of Oklahoma |
Surfactant microemulsions
|
US20200230066A1
(en)
*
|
2017-10-06 |
2020-07-23 |
The Regents Of The University Of California |
Self-Assembled Microcapsules for Optically Controlled Cargo Encapsulation and Release
|
CA3102967A1
(en)
*
|
2018-06-07 |
2019-12-12 |
Mannkind Corporation |
Composition and method for inhalation
|
AU2019325702A1
(en)
|
2018-08-24 |
2021-02-25 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|